학술논문
Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation
Document Type
Article
Author
Source
In Pulmonary Pharmacology & Therapeutics October 2015 34:37-45
Subject
Language
ISSN
1094-5539